Read the docs
TI-2026-77766 Aliases CVE-2026-101451GHSA-4qx6-pgv2-wfrv

Improper access control in Oracle Siebel Life Sciences Web UI

Priority LOW 39CWE-284Published · Updated

Key facts

Attack vector
Network
Privileges required
Low
User interaction
Required
Attack complexity
Low
Impact type
Security bypass, Tampering
Confidentiality · integrity · availability
High · High · None
Fix status
No fix listed

Attack profile from CVSS 3.1 · CNA. Fix status from CNA. Impact type from CWE-284 and CWE-352.

Summary

The Siebel Life Sciences product of Oracle Siebel CRM, versions 17.0 through 26.9, has an improper access control flaw in its Web UI component (CWE-284). A remote attacker with low privileges over HTTP can, if another user interacts with the attack, create, delete or modify critical data and access all data the product can reach. The attack can also affect other products because the scope changes.

Written with Claude Haiku 5.5 from the sources below · 2026-11-05

Description from the CNA

Vulnerability in the Siebel Life Sciences product of Oracle Siebel CRM (component: Web UI). Supported versions that are affected are 17.0-26.9. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Siebel Life Sciences. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Siebel Life Sciences, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Siebel Life Sciences accessible data as well as unauthorized access to critical data or complete access to all Siebel Life Sciences accessible data. CVSS 3.1 Base Score 8.7 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N).

Why it matters now

Exploitation None reported CISA SSVC · not in CISA KEV
EPSS 0.00157 4th percentileScored 2026-11-07
Fix No fix listed No fixed version in the sources yet

SSVC decision points

CISA ADP · SSVC 2.0.3

Exploitation
None
Automatable
No
Technical impact
Total

The decision (Track, Attend, Act) also depends on your mission and well-being impact; see CISA's SSVC guide.

Affected products

VendorProductAffected versionsFixed inStatusSource
OracleSiebel Life Sciences17.0 – 26.9—No fix listedCNA
  • Siebel Life Sciences VendorOracle Affected 17.0 – 26.9 Fixed in — No fix listed CNA

Remediation

The sources list no fixed version for Oracle Siebel Life Sciences.

Written with Claude Haiku 5.5 from the sources below · 2026-11-05

Timeline

  1. 2026-10-21 Threatist record created from CVE-2026-101451
  2. 2026-10-21 Alias added: GHSA-4qx6-pgv2-wfrv
  3. 2026-10-22 Priority changed: MEDIUM → LOW
  4. 2026-11-03 Weakness changed · CISA ADP
  5. 2026-11-03 CISA SSVC decision points changed
  6. 2026-11-03 Priority changed: LOW → MEDIUM
  7. 2026-11-05 Priority changed: MEDIUM → LOW

References

Advisory 1

  • TI-2026-34425 Improper privilege management in Oracle Payments KEVCVSS 3.1CRITICAL 9.8
  • TI-2026-27421 Missing authentication in Oracle PeopleSoft Enterprise PeopleTools KEVCVSS 3.1CRITICAL 9.8
  • TI-2026-17661 Improper access control in Oracle HTTP Server, Oracle Weblogic Server Proxy Plug-in KEVCVSS 3.1CRITICAL 10.0
  • TI-2025-38252 Improper authentication in Oracle Concurrent Processing KEVCVSS 3.1CRITICAL 9.8
  • TI-2025-38151 Missing authentication in Oracle Identity Manager KEVCVSS 3.1CRITICAL 9.8
  • TI-2022-07142 Code injection in Spring Framework KEVCVSS 3.1CRITICAL 9.8
See all 14200 →

Sources

This product uses the NVD API but is not endorsed or certified by the NVD. Sources and licences